Cargando…
Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease
Neutrophils are versatile innate effector cells essential for immune defense but also responsible for pathologic inflammation. This dual role complicates therapeutic targeting. However, neither neutrophils themselves nor the mechanisms they employ in different forms of immune responses are homogeneo...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409342/ https://www.ncbi.nlm.nih.gov/pubmed/30886615 http://dx.doi.org/10.3389/fimmu.2019.00346 |
_version_ | 1783401945474531328 |
---|---|
author | Grieshaber-Bouyer, Ricardo Nigrovic, Peter A. |
author_facet | Grieshaber-Bouyer, Ricardo Nigrovic, Peter A. |
author_sort | Grieshaber-Bouyer, Ricardo |
collection | PubMed |
description | Neutrophils are versatile innate effector cells essential for immune defense but also responsible for pathologic inflammation. This dual role complicates therapeutic targeting. However, neither neutrophils themselves nor the mechanisms they employ in different forms of immune responses are homogeneous, offering possibilities for selective intervention. Here we review heterogeneity within the neutrophil population as well as in the pathways mediating neutrophil recruitment to inflamed tissues with a view to outlining opportunities for therapeutic manipulation in inflammatory disease. |
format | Online Article Text |
id | pubmed-6409342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64093422019-03-18 Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease Grieshaber-Bouyer, Ricardo Nigrovic, Peter A. Front Immunol Immunology Neutrophils are versatile innate effector cells essential for immune defense but also responsible for pathologic inflammation. This dual role complicates therapeutic targeting. However, neither neutrophils themselves nor the mechanisms they employ in different forms of immune responses are homogeneous, offering possibilities for selective intervention. Here we review heterogeneity within the neutrophil population as well as in the pathways mediating neutrophil recruitment to inflamed tissues with a view to outlining opportunities for therapeutic manipulation in inflammatory disease. Frontiers Media S.A. 2019-03-04 /pmc/articles/PMC6409342/ /pubmed/30886615 http://dx.doi.org/10.3389/fimmu.2019.00346 Text en Copyright © 2019 Grieshaber-Bouyer and Nigrovic. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Grieshaber-Bouyer, Ricardo Nigrovic, Peter A. Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease |
title | Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease |
title_full | Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease |
title_fullStr | Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease |
title_full_unstemmed | Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease |
title_short | Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease |
title_sort | neutrophil heterogeneity as therapeutic opportunity in immune-mediated disease |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409342/ https://www.ncbi.nlm.nih.gov/pubmed/30886615 http://dx.doi.org/10.3389/fimmu.2019.00346 |
work_keys_str_mv | AT grieshaberbouyerricardo neutrophilheterogeneityastherapeuticopportunityinimmunemediateddisease AT nigrovicpetera neutrophilheterogeneityastherapeuticopportunityinimmunemediateddisease |